18th week of 2019 patent applcation highlights part 11 |
Patent application number | Title | Published |
20190125821 | COMPOSITION FOR TREATING AND PREVENTING RHEUMATOID ARTHRITIS | 2019-05-02 |
20190125822 | COMPOSITION FOR IMPROVING OR PREVENTING NONALCOHOLIC FATTY LIVER | 2019-05-02 |
20190125824 | POWDER FORMULATION | 2019-05-02 |
20190125825 | SMALL-MOLECULE ADJUVANTS FOR ANTIBIOTICS TO ADDRESS ANTIBIOTIC RESISTANCE | 2019-05-02 |
20190125826 | METHODS AND PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF INFLAMMATORY SKIN DISEASES ASSOCIATED WITH DESMOGLEIN-1 DEFICIENCY | 2019-05-02 |
20190125827 | LYSOSOMAL DEGRADATION OF LIPIDS AND PROTEINS AND METHOD OF USE THEREOF | 2019-05-02 |
20190125828 | COMPOSITIONS COMPRISING CHOLINE | 2019-05-02 |
20190125829 | METHOD FOR PREVENTING OBESITY-INDUCED FATTY LIVER BY INHIBITING KCTD17 | 2019-05-02 |
20190125830 | CO-ACTIVATION OF MTOR AND STAT3 PATHWAYS TO PROMOTE NEURONAL SURVIVAL AND REGENERATION | 2019-05-02 |
20190125831 | ANTI-INFECTIVE PROPERTIES OF ANTIFREEZE PROTEIN | 2019-05-02 |
20190125832 | PHARMACEUTICAL COMPOSITION FOR REDUCING THE SYMPTOMS AND DISEASE OF THE RESPIRATORY INFECTION CAUSED BY HUMAN METAPNEUMOVIRUS (HMPV), WHICH COMPRISES AT LEAST ONE AGENT THAT NEUTRALISES THE FUNCTION OF THE TSLP AND/OR TSLPR AND/OR OX40L AND/OR CD177 MOLECULES, AND A PHARMACEUTICALLY ACCEPTABLE EXCIPIENT, AND THE USE THEREOF | 2019-05-02 |
20190125833 | NOPE FOR TREATMENT OF PATHOLOGICAL MUSCLE LOSS AND WEAKNESS | 2019-05-02 |
20190125834 | NOVEL RECOMBINANT FUSION PROTEINS, PREPARATION AND USE THEREOF | 2019-05-02 |
20190125835 | COMPOSITION FOR REGULATING CUTANEOUS PIGMENTATION OR SKIN WHITENING COMPRISING SDF1 | 2019-05-02 |
20190125836 | USE OF aFGF FOR PREVENTING OR TREATING DISEASES RELATED TO MUSCLE WASTING | 2019-05-02 |
20190125837 | METHOD FOR THE TREATMENT OR PREVENTION OF OSTEOARTHRITIS | 2019-05-02 |
20190125838 | METHOD FOR THE TREATMENT OR PREVENTION OF OSTEOARTHRITIS | 2019-05-02 |
20190125839 | POLYNUCLEOTIDES ENCODING INTERLEUKIN-12 (IL12) AND USES THEREOF | 2019-05-02 |
20190125840 | COMBINATION THERAPY COMPRISING AN INFLAMMATORY IMMUNOCYTOKINE AND A CHIMERIC ANTIGEN RECEPTOR (CAR)-T CELL | 2019-05-02 |
20190125841 | STABLE FORMULATIONS FOR CNS DELIVERY OF ARYLSULFATASE A | 2019-05-02 |
20190125842 | LYSOSOMAL ACID LIPASE THERAPY FOR NAFLD AND RELATED DISEASES | 2019-05-02 |
20190125843 | Use of antiplatelet thrombolysin in the preparation of medicine for treating thrombotic thrombocytopenic purpura | 2019-05-02 |
20190125844 | NEUROTOXIN COMPOSITIONS FOR USE IN IMPROVING LUNG FUNCTION | 2019-05-02 |
20190125845 | COMPOSITIONS AND METHODS FOR TREATMENT OF HOMOCYSTINURIA | 2019-05-02 |
20190125846 | NEW IMMUNOBIOLOGICAL PRODUCTS | 2019-05-02 |
20190125847 | Methods, Antibodies, and Vaccines Utilizing Epitopes of Alpha Synuclein for Treatment of Parkinson's Disease | 2019-05-02 |
20190125848 | DENDRITIC CELL-EXTRACELLULAR VESICLE FUSIONS AND METHODS OF USING SAME | 2019-05-02 |
20190125849 | SCAFFOLDS FOR CELL TRANSPLANTATION | 2019-05-02 |
20190125850 | IMMUNOTHERAPY FOR CANCER | 2019-05-02 |
20190125851 | CYTOKINE SIGNALING IMMUNOMODULATORS AND METHODS | 2019-05-02 |
20190125852 | COMPOSITIONS AND METHODS FOR TUMOR VACCINATION USING PROSTATE CANCER-ASSOCIATED ANTIGENS | 2019-05-02 |
20190125853 | NOROVIRUS VACCINE FORMULATIONS | 2019-05-02 |
20190125854 | VACCINE AGAINST RSV | 2019-05-02 |
20190125855 | RAPID METHOD OF GENERATING LIVE ATTENUATED VACCINES | 2019-05-02 |
20190125856 | Improvement of L2 Peptide Immunogenicity | 2019-05-02 |
20190125857 | NUCLEIC ACID MOLECULES AND USES THEREOF | 2019-05-02 |
20190125858 | COLD ADAPTED AND VIRULENCE FACTOR DELETED LIVE ATTENUATED VACCINE SUITABLE FOR MUCOSAL DELIVERY | 2019-05-02 |
20190125859 | INFLUENZA VIRUS VACCINATION REGIMENS | 2019-05-02 |
20190125860 | Equine Influenza Virus Live Attenuated Vaccines | 2019-05-02 |
20190125861 | RSV F Protein Mutants | 2019-05-02 |
20190125862 | IMPROVED METHOD FOR PRODUCING VIRUS LIKE PARTICLES | 2019-05-02 |
20190125863 | NANOEMULSION ADJUVANT FOR NASAL MUCOSA AND PREPARATION METHOD THEREOF | 2019-05-02 |
20190125864 | COMBINATION THERAPY OF RAMUCIRUMAB AND ABEMACICLIB FOR USE IN TREATMENT OF MANTLE CELL LYMPHOMA | 2019-05-02 |
20190125865 | METHODS FOR TREATING OR PREVENTING ASTHMA BY ADMINISTERING AN IL-4R ANTAGONIST | 2019-05-02 |
20190125866 | AGONIST ANTIBODIES THAT BIND HUMAN CD137 AND USES THEREOF | 2019-05-02 |
20190125867 | THERAPEUTIC AGENT FOR SOLID CANCER | 2019-05-02 |
20190125868 | HIGH CONCENTRATION IMMUNOGLOBULIN COMPOSITION FOR PHARMACEUTICAL APPLICATION | 2019-05-02 |
20190125869 | PULSED ELECTROMAGNETIC THERAPY FOR DIRECTING AGENTS TO CANCER CELLS | 2019-05-02 |
20190125870 | PHOTOCLEAVABLE DRUG CONJUGATES | 2019-05-02 |
20190125871 | DEVICES, SYSTEMS AND METHODS FOR OPTOGENETIC MODULATION OF ACTION POTENTIALS IN TARGET CELLS | 2019-05-02 |
20190125872 | PERIODONTAL REGENERATION COMPOSITION AND METHOD OF USING SAME | 2019-05-02 |
20190125873 | GLUCOSAMINE PEPTIDE COMPOUNDS FOR TREATING LIVER METABOLIC DISORDERS | 2019-05-02 |
20190125874 | POLY (BETA-AMINO ESTERS) AND USES THEREOF | 2019-05-02 |
20190125875 | ATAZANAVIR SULFATE FORMULATIONS WITH IMPROVED Ph EFFECT | 2019-05-02 |
20190125876 | METHOD FOR MANUFACTURING NUCLEIC ACID FILM AND APPARATUS FOR INJECTING MEDICINE USING NUCLEIC ACID FILM | 2019-05-02 |
20190125877 | Ophthalmic Composition | 2019-05-02 |
20190125878 | POLYMER-BASED SUSTAINED RELEASE DEVICE | 2019-05-02 |
20190125879 | ITRACONAZOLE COMPOSITIONS AND DOSAGE FORMS, AND METHODS OF USING THE SAME | 2019-05-02 |
20190125880 | TOPICAL COMPOSITIONS FOR IMPROVED DELIVERY OF ACTIVE AGENTS | 2019-05-02 |
20190125881 | STABLE LIQUID FORMULATIONS FOR PHARMACEUTICALS AND SUPPLEMETNTS | 2019-05-02 |
20190125882 | ISATOIC ANHYDRIDE DERIVATIVES AND APPLICATIONS THEREOF | 2019-05-02 |
20190125883 | PEPTIDE DRUG IMPROVEMENT USING VITAMIN B12 AND HAPTOCORRIN BINDING SUBSTRATE CONJUGATES | 2019-05-02 |
20190125884 | COMPOUNDS AND METHODS FOR TRANS-MEMBRANE DELIVERY OF MOLECULES | 2019-05-02 |
20190125885 | STABILIZATION OF BIOMOLECULES USING SUGAR POLYMERS | 2019-05-02 |
20190125886 | COMPOSITIONS AND METHODS FOR THE PROPHYLAXIS AGAINST AND THE TREATMENT OF THE ADHESION PROCESS | 2019-05-02 |
20190125887 | CONJUGATES OF BIOLOGICALLY ACTIVE MOLECULES TO FUNCTIONALIZED POLYMERS | 2019-05-02 |
20190125888 | TARGETED CONJUGATES AND PARTICLES AND FORMULATIONS THEREOF | 2019-05-02 |
20190125889 | IMMUNOGENIC COMPOUND | 2019-05-02 |
20190125890 | Novel Scaffolded HIV-1 Vaccine Immunogens | 2019-05-02 |
20190125891 | COMPOSITIONS AND METHODS FOR TISSUE REPAIR | 2019-05-02 |
20190125892 | BINDING PROTEIN DRUG CONJUGATES COMPRISING ANTHRACYCLINE DERIVATIVES | 2019-05-02 |
20190125893 | PYRROLOBENZODIAZEPINE CONJUGATES | 2019-05-02 |
20190125894 | NOVEL HYDROPHILIC LINKERS AND LIGAND-DRUG CONJUGATES THEREOF | 2019-05-02 |
20190125895 | LAYER-BY-LAYER NANOPARTICLES FOR CYTOKINE THERAPY IN CANCER TREATMENT | 2019-05-02 |
20190125896 | ANTI-INFECTIVE COMPOSITIONS COMPRISING PHYTOGLYCOGEN NANOPARTICLES | 2019-05-02 |
20190125897 | ANTIMICROBIAL AGENTS AGAINST SALMONELLA BACTERIA | 2019-05-02 |
20190125898 | NIPAH VIRUS ENVELOPE PSEUDOTYPED LENTIVIRUSES AND METHODS OF THEIR USE | 2019-05-02 |
20190125899 | METHODS AND COMPOSITIONS FOR TREATING METABOLIC IMBALANCE | 2019-05-02 |
20190125900 | EXPRESSION OF NEUROPEPTIDES | 2019-05-02 |
20190125901 | COMPOSITIONS AND SYSTEMS FOR RENAL FUNCTION DETERMINATION | 2019-05-02 |
20190125902 | METHODS FOR RENAL FUNCTION DETERMINATION | 2019-05-02 |
20190125903 | UPAR TARGETING PEPTIDE FOR USE IN PEROPERATIVE OPTICAL IMAGING OF INVASIVE CANCER | 2019-05-02 |
20190125904 | Pulsing High Intensity Narrow Spectrum Light | 2019-05-02 |
20190125905 | Antimicrobial Backlit Device | 2019-05-02 |
20190125906 | CONTAINERS AND SYSTEMS FOR PROCESSING A FLUID | 2019-05-02 |
20190125907 | Ultraviolet Disinfection for a Water Bottle | 2019-05-02 |
20190125908 | SYSTEM AND METHOD FOR IMPROVED CLEANING AND SANITIZING OF SURFACES USING ELECTROLYZED SOLUTIONS | 2019-05-02 |
20190125909 | PROCESS OF EMITTING OF HYDROGEN PEROXIDE VAPOR | 2019-05-02 |
20190125910 | Re-Phresh System | 2019-05-02 |
20190125911 | DECONTAMINATION DEVICE FOR PHARMACEUTICAL VESSELS HAVING SAFETY MECHANISMS | 2019-05-02 |
20190125912 | REMOVABLE CARTRIDGES FOR USE WITH PROCESS MONITORING SYSTEMS, AND SYSTEMS COMPRISING SAME | 2019-05-02 |
20190125913 | SOLID AIR FRESHENER | 2019-05-02 |
20190125914 | GAS-PERMEABLE DEVICES WHICH ABSORB VOC AND/OR POLLUTANTS AND/OR ARE BIOCIDAL, AND USE THEREOF | 2019-05-02 |
20190125915 | SYSTEMS AND METHODS FOR DIFFUSING ESSENTIAL OILS | 2019-05-02 |
20190125916 | SCENT DISPENSER/ABSORBER AND METHOD USING SAME | 2019-05-02 |
20190125917 | AIR CLEANER | 2019-05-02 |
20190125918 | FREEZER FOR BIOSANITARY AND CYTOTOXIC WASTE | 2019-05-02 |
20190125919 | SYSTEMS AND METHODS FOR PURIFYING AN ENVIRONMENT | 2019-05-02 |
20190125920 | Method and System for Generating Non-Thermal Plasma | 2019-05-02 |
20190125921 | WATER-ABSORBING AGENT AND METHOD FOR PRODUCING SAME, AND ABSORBENT ARTICLE PRODUCED USING WATER-ABSORBING AGENT | 2019-05-02 |